2018 -2021 EVP of R and D and Chief Medical Officer @
2018 -2018 Interim CEO @
2017 -2018 Entrepreneur In Residence @
2015 -2016 Chief Medical Officer @
2013 -2014 Chief Medical Officer @
2009 -2013 Vice President, Clinical Development @
2005 -2009 Executive Director, Clinical Development @
Krishna Polu Education
Stanford University Graduate School of Business
Certificate (Directors Consortium)
2021
Harvard Medical School
(Fellowship in Nephrology)
2003-2005
University of Colorado Anschutz
(Residency in Internal Medicine)
1999-2003
UT Health San Antonio
MD
1995-1999
Stanford University
BA (Human Biology)
1991-1995
Krishna Polu Skills
Clinical Development
Biotechnology
Cardiovascular Medicine
Pharmacovigilance
Risk Management
Nephrology
Oncology
FDA
Diabetes
Internal Medicine
Therapeutic Areas
Lifesciences
EDC
CRO
Medicine
Pharmaceutical Industry
Clinical Research
Pharmaceutical Sales
Neurology
Drug Development
Translational Medicine
IND
Clinical Trials
Biopharmaceuticals
Cancer
Microsoft Excel
Marketing
Research
Sales
Leadership
Business Development
Teaching
Healthcare
Krishna Polu Summary
Krishna Polu, based in California, United States, is currently a President and CEO at R1 Therapeutics. Krishna Polu brings experience from previous roles at Abingworth, Catalys Pacific, Lupus Ventures and Lupus Research Alliance. Krishna Polu holds a Certificate in Directors Consortium @ Stanford University Graduate School of Business. With a robust skill set that includes Clinical Development, Biotechnology, Cardiovascular Medicine, Pharmacovigilance, Risk Management and more. Krishna Polu has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Krishna Polu?
Find contact details for 700 million professionals.